David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Hastings Center Report 36 (1):57-63 (2006)
Stem cell therapies should be available to people of all ethnicities. However, most cells used in the clinic will probably come from lines of cells stored in stem cell banks, which may end up benefiting the majority group most. The solution is to seek additional funding, earmarked for lines that will benefit minorities and offered as a public expression of apology for past discrimination
|Keywords||stem cell race therapy apology expressive good|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Insoo Hyun (2010). Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges. Journal of Law, Medicine and Ethics 38 (2):277-285.
Mark T. Brown (2009). Moral Complicity in Induced Pluripotent Stem Cell Research. Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
Alexander Pruss, Cooperation with Past Evil and Use of Cell-Lines Derived From Aborted Fetuses Alexander R. Pruss May 25, 2004.
Lawrence Burns (2009). “You Are Our Only Hope”: Trading Metaphorical “Magic Bullets” for Stem Cell “Superheroes”. Theoretical Medicine and Bioethics 30 (6):427-442.
Cynthia B. Cohen Peter J. Cohen (2010). International Stem Cell Tourism and the Need for Effective Regulation: Part II: Developing Sound Oversight Measures and Effective Patient Support. Kennedy Institute of Ethics Journal 20 (3):207-230.
Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Mark Greene, Patricia King, Stephen J. O'Brien, David H. Sachs, Kathryn E. Schill, Andrew Siegel & Davor Solter (2003). Safety Issues In Cell-Based Intervention Trials. Fertility and Sterility 80 (5):1077-1085.
Mark S. Moller (2008). Human Embryonic Stem Cell Research, Justice, and the Problem of Unequal Biological Access. Philosophy, Ethics, and Humanities in Medicine 3 (1):22.
Melinda B. Fagan (2011). Social Experiments in Stem Cell Biology. Perspectives on Science 19 (3):235-262.
Added to index2009-01-28
Total downloads6 ( #194,715 of 1,096,548 )
Recent downloads (6 months)2 ( #150,143 of 1,096,548 )
How can I increase my downloads?